Key result
Laser catheter ablation of long-lasting persistent atrial fibrillation achieved a 96% lifelong success rate in maintaining sinus rhythm over a mean follow-up of 8.2 years.
Why the study?
Does laser catheter ablation improve long-term sinus rhythm maintenance in patients with drug-resistant long-lasting persistent atrial fibrillation?
Observational (n=48)
No
Does laser catheter ablation improve long-term sinus rhythm maintenance in patients with drug-resistant long-lasting persistent atrial fibrillation?
Laser catheter ablation using an ELMA catheter demonstrates high long-term efficacy and safety for maintaining sinus rhythm in patients with drug-resistant long-lasting persistent atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support durable sinus rhythm in selected persistent AF cases; leaves open need for randomized confirmation before practice change.
Catheter ablation of atrial fibrillation (AF) is a current therapeutic option but its efficacy for the treatment of long-lasting persistent AF (l-lpAF) remains suboptimal. We tested the laser method as an alternative for catheter ablation of l-lpAF by using an open-irrigated electrode laser mapping and ablation (ELMA) catheter. Laser ablation was attempted in 48 patients aged 50-81 years (69 ± 7.6 y, female = 28) with drug resistant (3.5 trials) l-lpAF (≥12 months). All of the patients had comorbidities: congestive heart failure NYHA II-III (100%), hypertension 29 (60%), coronary artery disease 19 (40%), and heart valve defect 17 (35%). None of the patients had diabetes or obstructive sleep apnea. All were in AF at the beginning of the procedure. Continuous wave (cw) 1064nm Nd:YAG laser applications at 15W/10-20s (14-26/patient) were applied via the ELMA catheter until local electrical activity displayed on the monitor in the bipolar focused local electrograms (LEG) recorded via the pin electrodes from the tip of the catheter was abolished permanently and sinus rhythm was achieved. Online monitoring of electrical potential amplitudes in the focused LEG recorded via the pin-electrodes of the ELMA catheter allowed for validation of ablation success. Procedure duration ranged from 82-175 min (118 ± 72 min), number of lesions were14-26 (19 ± 4) per patient and X-ray exposure times ranged from 15-82 min (23.2 ± 12 min). Interventions were without complications. After the ablation procedure all the patients were in sinus rhythm, off medication, however, 12 (25%) needed a repeat study for various arrhythmias. During followup of 9 months to 29.3 years (8.2 ± 6.5 years) patients' quality of life improved significantly and during final follow-up control all except two were off medication still in sinus rhythm (lifelong success rate = 96%). As compared to other catheter ablation methods the laser method is an intriguing alternative for catheter ablation of l-lpAF.
No takes yet. Share an insight, caveat, or question.
Wéber et al. (2017) conducted an observational in Long-lasting persistent atrial fibrillation (n=48). Laser catheter ablation (ELMA catheter, Nd:YAG laser) was evaluated on Lifelong success rate (maintenance of sinus rhythm). Laser catheter ablation of long-lasting persistent atrial fibrillation achieved a 96% lifelong success rate in maintaining sinus rhythm over a mean follow-up of 8.2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: